ProPhase Labs (PRPH) to Release Quarterly Earnings on Wednesday

ProPhase Labs (NASDAQ:PRPH) is anticipated to release its Q2 2025 earnings data before the market opens on Wednesday, August 13th. Analysts expect ProPhase Labs to post earnings of ($0.15) per share and revenue of $3.55 million for the quarter.

ProPhase Labs (NASDAQ:PRPH) last released its earnings results on Tuesday, May 20th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.06. The company had revenue of $1.43 million for the quarter, compared to the consensus estimate of $2.45 million. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ProPhase Labs Stock Performance

PRPH opened at $0.28 on Tuesday. ProPhase Labs has a 52-week low of $0.22 and a 52-week high of $3.00. The firm has a market capitalization of $11.70 million, a PE ratio of -0.22 and a beta of -0.48. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.98 and a current ratio of 1.03. The business’s 50-day simple moving average is $0.37 and its 200 day simple moving average is $0.36.

ProPhase Labs Company Profile

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.